Literature DB >> 23449109

Adipokines: novel players in rheumatic diseases.

Javier Conde1, Morena Scotece, Verónica López, Rodolfo Gómez, Francisca Lago, Jesús Pino, Juan Jesús Gómez-Reino, Oreste Gualillo.   

Abstract

A large body of evidence from clinical and experimental studies is aiding to understand the close relationships between obesity and rheumatic diseases. For instance, it is generally accepted that obesity contributes to the development of osteoarthritis by increasing mechanical load of the joints, at least in weight bearing joints. However, besides mechanical effects, recent studies demonstrated that white adipose tissue is able to secrete a plethora of soluble factors, called adipokines, which have a critical role in the development and progression of some rheumatic diseases such as osteoarthritis and rheumatoid arthritis. In this article, we summarize the recent findings on the interaction of certain adipokines with the two most common rheumatic diseases: osteoarthritis and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449109

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  19 in total

1.  [Adiponectin as target in rheumatoid arthritis].

Authors:  E Neumann; K W Frommer; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

2.  [Interaction between bone, fat and insulin].

Authors:  J Luther; J-P David
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

Review 3.  The influence of ageing on the development and management of rheumatoid arthritis.

Authors:  Annemieke M H Boots; Andrea B Maier; Piet Stinissen; Pierre Masson; Rik J Lories; Filip De Keyser
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

Review 4.  Adipokines and inflammation: is it a question of weight?

Authors:  Vera Francisco; Jesus Pino; Miguel Angel Gonzalez-Gay; Antonio Mera; Francisca Lago; Rodolfo Gómez; Ali Mobasheri; Oreste Gualillo
Journal:  Br J Pharmacol       Date:  2018-04-10       Impact factor: 8.739

5.  E74-like factor 3 and nuclear factor-κB regulate lipocalin-2 expression in chondrocytes.

Authors:  Javier Conde; Miguel Otero; Morena Scotece; Vanessa Abella; Verónica López; Jesús Pino; Rodolfo Gómez; Francisca Lago; Mary B Goldring; Oreste Gualillo
Journal:  J Physiol       Date:  2016-07-18       Impact factor: 5.182

6.  Patient obesity is associated with severity of proximal humerus fractures, not outcomes.

Authors:  Blake I Boadi; Rebekah Belayneh; Connor P Littlefield; Kenneth A Egol
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-20       Impact factor: 3.067

7.  Identification of novel adipokines in the joint. Differential expression in healthy and osteoarthritis tissues.

Authors:  Javier Conde; Morena Scotece; Vanessa Abella; Rodolfo Gómez; Verónica López; Rosa Villar; Miguel Hermida; Jesús Pino; Juan Jesús Gómez-Reino; Oreste Gualillo
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

8.  Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota.

Authors:  Kei Arimatsu; Hitomi Yamada; Haruna Miyazawa; Takayoshi Minagawa; Mayuka Nakajima; Mark I Ryder; Kazuyoshi Gotoh; Daisuke Motooka; Shota Nakamura; Tetsuya Iida; Kazuhisa Yamazaki
Journal:  Sci Rep       Date:  2014-05-06       Impact factor: 4.379

9.  Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts.

Authors:  Béatrice Bouvard; Elie Abed; Mélissa Yéléhé-Okouma; Arnaud Bianchi; Didier Mainard; Patrick Netter; Jean-Yves Jouzeau; Daniel Lajeunesse; Pascal Reboul
Journal:  Arthritis Res Ther       Date:  2014-10-14       Impact factor: 5.156

10.  SERPINE2 Inhibits IL-1α-Induced MMP-13 Expression in Human Chondrocytes: Involvement of ERK/NF-κB/AP-1 Pathways.

Authors:  Anna Santoro; Javier Conde; Morena Scotece; Vanessa Abella; Ana Lois; Veronica Lopez; Jesus Pino; Rodolfo Gomez; Juan J Gomez-Reino; Oreste Gualillo
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.